("Amneal" or the "Company"), a global pharmaceutical company, today announced the advancement of two key strategic initiatives. First, the Company has resubmitted to the U.S. Food and Drug ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

Teva loses US appeal to keep inhaler patents on FDA protected drug list December 20, 2024 Amneal Pharmaceuticals has sued Colorado in an effort to block a state law requiring it to provide free ...

In this article, we are going to take a look at where Amneal Pharmaceuticals ... Rising Demand for GLP-1 Medications: Opportunities and Challenges in Diabetes and Obesity Treatment The management ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Amneal Pharmaceuticals (AMRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

The subsidiary seeks damages and injunctions. Vandana Singh Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts Amneal Pharmaceuticals Q3 sales rose 13% to $702.47 ...

"And to claim that drug, the patent must claim at least the active ingredient." The case is Teva Branded Pharmaceutical Products R&D Inc v. Amneal Pharmaceuticals of New York LLC, U.S. Court of ...

the court affirmed a win for Amneal Pharmaceuticals (AMRX) in a decision that would remove patents related to Teva Pharmaceuticals’ (TEVA) ProAir HFA inhaler from the Food and Drug ...

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.

The reasons for the shortages vary depending on who makes the generic medication. For example, Alvogen and Sun Pharma cite “regulatory delays” for their shortages. But Amneal, Hikma ...